St. Jude Researchers Lead Global Consensus Guidelines for Pediatric Diseases
St. Jude Children’s Research Hospital experts are creating evidence-informed consensus guidelines covering brain tumor diagnosis, pharmacogenomics, survivorship care, and rare blood disorders. Their work helps clinicians translate the latest data into improved diagnosis, treatment, and follow-up care globally.
St. Jude Children’s Research Hospital researchers are writing and updating consensus guidelines across multiple pediatric diseases, aiming to help clinicians worldwide translate the latest evidence into improved diagnosis, treatment, and follow-up care. The guidelines span areas including brain tumor diagnosis, pharmacogenomics, survivorship care, and rare blood disorders.
The work is led by experts such as Kelly Caudle, David Ellison, Matthew Ehrhardt, and Marcin Wlodarski, who are shaping how evidence becomes action. Their efforts help distinguish pediatric brain tumor subtypes, support genetics-informed prescribing, refine surveillance for childhood cancer survivors, and build consensus for rare disorders where large clinical trials may not be feasible.
“For many pediatric diseases, St. Jude has developed excellent internal standards, and we have worked to create general standards from there that we have published with experts worldwide,” Wlodarski said.
By helping develop global, evidence-informed standards, St. Jude is making discoveries usable in clinical care around the world.